GlaxoSmithKline Consumer Healthcare posts revenue of ₹ 1,180 crore in fourth quarter
Board of Directors recommends a dividend at the rate of Rs 75 per equity share for the 12 months period ended March 31, 2018
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
We want to be the No.1 dermocosmetic brand in India : Sanjay Sahu, MD, NAOS Skin Care
Sanjay Sahu, MD, NAOS Skin Care, in a detailed conversation with Usha Sharma, shares more details about the company’s details and…
Novartis India appoints Milan Paleja as VC and MD
Paleja is a graduate from Bombay University and holds a Cost Accountants degree from the Institute of Cost Accountants of India
Glenmark Pharma gets US FDA nod for skin treatment cream
For the 12 months to March 2018, Temovate cream achieved annual sales of approximately $118 million
Zydus Cadila gets US FDA nod for Carbidopa tablets
The drug will be manufactured at the group's manufacturing facility at SEZ, Ahmedabad
Lupin launches Corcal Bone and Beauty supplement
Corcal Bone and Beauty is available in packs of 10 mini-tablets
Epygen plans to raise Rs 300 cr to propel biosimilars in India
The funds will be utlilised for clinical trials of pipeline molecules and securing IP for technologies for novel biological…
Glenmark Pharma to present updated info on GBR 830 at International Investigative Dermatology…
GBR 830 is a first-in-class, investigational, anti-OX40 monoclonal antibody for treatment of moderate-to-severe atopic dermatitis
Annual Opex in Pharma Summit to be held in Mumbai
The event will discuss on how pharma manufacturers should efficiently implement excellence initiatives
Cipla partners with MannKind for Afrezza – inhaled insulin
Signs deal for exclusive marketing and distribution of the only US FDA approved inhaled insulin